A cell replacement therapy that uses retinal pigment epithelium-derived stem cells is showing the potential to restore retinal tissue in advanced age-related macular degeneration with geographic atrophy.
“When we designed the trial, our aim was to stop or slow down the progression of geographic atrophy (GA), and much to our surprise, we found that this therapy not only prevented progression but restored the outer retinal layer. This is a tremendous milestone, a real breakthrough, something that has not been seen ever,” Jordi Monés, MD, PhD, director of the Institut de la Màcula